Show simple item record

dc.contributor.authorWalsh, Seán
dc.contributor.authorvan der Putten, Wil
dc.date.accessioned2014-07-08T09:22:49Z
dc.date.available2014-07-08T09:22:49Z
dc.date.issued2013-03
dc.identifier.citationA TCP model for external beam treatment of intermediate-risk prostate cancer. 2013, 40 (3):031709 Med Physen_GB
dc.identifier.issn0094-2405
dc.identifier.pmid23464304
dc.identifier.doi10.1118/1.4790469
dc.identifier.urihttp://hdl.handle.net/10147/322549
dc.description.abstractBiological models offer the ability to predict clinical outcomes. The authors describe a model to predict the clinical response of intermediate-risk prostate cancer to external beam radiotherapy for a variety of fractionation regimes.
dc.language.isoenen
dc.rightsArchived with thanks to Medical physicsen_GB
dc.subject.meshDose Fractionation
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshModels, Statistical
dc.subject.meshProbability
dc.subject.meshProstatic Neoplasms
dc.subject.meshRadiobiology
dc.subject.meshRisk
dc.subject.meshTreatment Outcome
dc.titleA TCP model for external beam treatment of intermediate-risk prostate cancer.en_GB
dc.typeArticleen
dc.contributor.departmentSchool of Physics, National University of Ireland Galway, Connacht, Ireland. Walshsharp@gmail.comen_GB
dc.identifier.journalMedical physicsen_GB
dc.description.fundingNo fundingen
dc.description.provinceConnachten
dc.description.peer-reviewpeer-reviewen
html.description.abstractBiological models offer the ability to predict clinical outcomes. The authors describe a model to predict the clinical response of intermediate-risk prostate cancer to external beam radiotherapy for a variety of fractionation regimes.


This item appears in the following Collection(s)

Show simple item record